An all-oral treatment regimen for multidrug-resistant tuberculosis (MDR-TB) recently recommended as a new standard of care by the World Health Organization is effective and safe in people living with HIV, Dr Ilaria Motta of Médecins sans Frontières reported at the 24th International AIDS Conference (AIDS 2022) in Montreal.
However, activists at the conference say that all-oral treatment remains out of reach for many people in the worst-affected countries, as they launched the 1 / 4 / 6 x 24 campaign to galvanise public health programmes into investing in sufficient “staff, stuff, space, systems, and support” to make new shorter regimens for TB treatment available to all by 2024.
Read the full story at Aidsmap.
Source: Aidsmap